Home

The Sri Lanka Association of Clinical Pharmacology and Therapeutics (SLACPT), is the national professional association for Clinical Pharmacology and Therapeutics in Sri Lanka. Established in 2015, the SLACPT is a non-profit organisation, and its members contribute towards its many activities entirely voluntarily. The Association serve as a catalyst for professional and academic development of its members, and it is committed to developing the field of Clinical Pharmacology and Therapeutics in Sri Lanka. The association further aims to promote best practices in utilisation of medicines for improved patient care, whilst being an advocacy body on policy and regulation of pharmaceuticals in the country. The members of SLACPT are a diverse group of medical professionals who possess both scientific and clinical expertise. This unique combination enables the SLACPT to effectively play a vital role in improving patient care through its many activities and publications. 

Professor Priyadarshani Galappatthy – President SLACPT
MBBS (Col), MD (Col), MRCP (UK), DipMedTox (Cardiff), FCCP, FRCP (Lond)

SLACPT was established in 2015 with a vision to be the opinion leader in Clinical Pharmacology and Therapeutics (CPT) in Sri Lanka. An Association to promote and advance the discipline and represent the profession of clinical pharmacology and therapeutics was non-existent and the SLACPT was formed to serve that purpose.

The SLACPT has selected the theme ‘Safer, equitable and quality use of medicines for challenging times’ to conduct its activities for the period 2023-2024, considering the unprecedented challenges the country is currently facing due to the economic crisis. SLACPT is providing advocacy and guidance to the Ministry of Health on strategies to ensure equitable supply of medicines by promoting principles of essential medicines concept, transparent selection processes for purchasing, effective regulation, good governance and cost-effective, quality usage of medicines.

Ensuring the safety of medicines is a current topic of interest and a critical issue considering the numbers of patients harmed due to medication errors that occur globally, as highlighted by the World Health Organisation (WHO). Responding to this, the Ministry of Health developed a national action plan on medication safety with leadership provided by SLACPT members. We plan to provide further guidance and leadership in implementing the key components of the national action plan.

SLACPT plans to work collaboratively with all medical speciality Colleges and professional Associations, the Ministry of Health, WHO and International organisations representing the field of Pharmacology to foster the discipline and to achieve the objects of the SLACPT. We look forward to the active contribution and collaboration of all stakeholders to promote safer, economical, equitable and quality use of medicines to people of Sri Lanka, especially during these challenging times.